UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 28, 2011
ARTHROCARE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction |
| 0-027422 (Commission File Number) |
| 94-3180312 (I.R.S. Employer Identification |
7000 West William Cannon, Building One |
|
|
Austin, TX |
| 78735 |
(Address of principal executive offices) |
| (Zip Code) |
(512) 391-3900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
On November 28, 2011 ArthroCare Corporation (“ArthroCare”) issued a press release describing an agreement in principle to settle the private securities class action cases currently pending against ArthroCare. A copy of the memorandum is attached hereto as Exhibit 99.1 and incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
| Description |
|
|
|
99.1 |
| Press Release Dated November 28, 2011. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| ARTHROCARE CORPORATION |
|
|
|
|
|
|
Date: November 28, 2011 | By: | /s/ David Fitzgerald |
|
| David Fitzgerald |
|
| Acting President and Chief Executive Officer |